Vitamin D and Calcium Supplementation in Breast Cancer
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
This study aims at assessing the vitamin Dstatus in breast cancer patients who receive
letrozole for more than two months and to evaluate effects of vitamin D3 and calcium
supplementation on arthalgia caused by letrozole on these patients.